Home » Stocks » Enochian Biosciences

Enochian Biosciences, Inc. (ENOB)

Stock Price: $3.92 USD 0.16 (4.26%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
After-hours: $3.93 +0.01 (0.26%) Jul 10, 5:39 PM

Stock Price Chart

Key Info

Market Cap 182.27M
Revenue (ttm) n/a
Net Income (ttm) -334,047
Shares Out 46.50M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $3.92
Previous Close $3.76
Change ($) 0.16
Change (%) 4.26%
Day's Open 3.82
Day's Range 3.82 - 3.99
Day's Volume 55,910
52-Week Range 1.95 - 13.43

More Stats

Market Cap 182.27M
Enterprise Value 178.90M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 46.50M
Float 3.66M
EPS (basic) 0.03
EPS (diluted) -0.14
FCF / Share -0.23
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.38M
Short Ratio 1.11
Short % of Float 9.71%
Beta 0.41
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 1.10
Revenue n/a
Operating Income -5.39M
Net Income -334,047
Free Cash Flow -10.60M
Net Cash 3.37M
Net Cash / Share 0.07
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -4.00%
ROE -3.91%
ROIC -7.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-10.99-5.33-2.40
Net Income-18.02-6.31-2.14
Shares Outstanding37.5521.9412.27
Earnings Per Share-0.48-0.29-0.17
Operating Cash Flow-8.51-4.34-1.18
Capital Expenditures-0.72-0.03-
Free Cash Flow-9.22-4.37-1.18
Cash & Equivalents12.2815.603.94
Total Debt--2.09
Net Cash / Debt12.2815.601.85
Book Value1731591.53
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Enochian Biosciences, Inc.
Country United States
Employees 8

Stock Information

Ticker Symbol ENOB
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ENOB


Enochian Biosciences Inc., a pre-clinical stage biotechnology company, focuses on development of human therapeutics for infectious diseases and cancers. The company's lead candidate include ENOB-HV-01 for autologous HIV curative treatment. Its pipeline development products consist of ENOB-HV-11, a preventive HIV vaccine; and ENOB-HV-12, a therapeutic HIV vaccine. The company's pipeline development products also include ENOB-DB-01, a therapeutic cancer vaccine for the long term maintenance and prevention of relapse for the treatment of stage III and IV colon cancer patients; ENOB-DC-11 Innovative DC vaccine for multiple solid tumors; and ENOB-DC-21 for intratumoral injection. The company has strategic partnerships with The Scripps Institute and Fred Hutchinson Cancer Center. Enochian BioSciences was incorporated in 2017 and is based in Los Angeles, California.